Loading...
Loss of p21(Cip1/CDKN1A) renders cancer cells susceptible to Polo-like kinase 1 inhibition
The deregulation of Polo-like kinase 1 is inversely linked to the prognosis of patients with diverse human tumors. Targeting Polo-like kinase 1 has been widely considered as one of the most promising strategies for molecular anticancer therapy. While the preclinical results are encouraging, the clin...
Na minha lista:
| Udgivet i: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals LLC
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4466638/ https://ncbi.nlm.nih.gov/pubmed/25483104 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|